Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions

Researchers tackling deadly TB discuss the way forward in treatment and prevention

Researchers from across the world who are tacking the deadly bacterial disease tuberculosis (TB) attended a symposium at St George’s, University of London to discuss the way forward in treatment and prevention.

TB is one of the top 10 causes of death worldwide and in 2016, 10.4 million people fell ill with the disease and another 1.7 million died. Many of the deaths – 95% according to the World Health Organization – are among people have immune systems damaged by HIV.

The International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis (INTERTB) group of experts meeting at St George’s was organized by Dr Amina Jindani, an Honorary Senior Lecturer.

So INTERTB is a consortium of all the groups in the world who carry out trials to improve treatment for drug-sensitive TB, and they have met annually at St George’s since 2009.

Dr Jindani was involved in some of the first TB drugs trials 50 years ago.

She explained: “When I started working in TB, the treatment was 18 months, and although the regimen was very effective, 18 months was just too long, and very few people completed the treatment.

“When two new drugs became available in the 1960s, rifampicin and pyrazinamide, from preclinical studies, it was thought that they would be able to shorten the treatment duration. The very first short course study that was ever done using these two drugs was done by the MRC, and I coordinated it in 42 centers in Kenya, Tanzania, Uganda and Zambia.”

Dr Jindani explained: “In spite of having a very effective six month treatment, the annual incidence is not decreasing; and the annual mortality remains at nearly 2 million in this is a curable disease. Why should 5000 people globally a day die of a curable disease? In any other situation it would be an outrage.”

“We have a safe, well-tolerated, highly effective treatment regimen but six months is still too long. After the first two months they feel well again, and so they stop taking their treatment.

“Then they relapse – if they relapse with drug-sensitive organisms that’s fine, but sometimes they relapse with drug-resistant organisms.  What we need is an effective vaccine, but in the absence of that, the only thing we can do to encourage compliance and completion of treatment, and increase the cure rates, is to reduce treatment duration.”

Rather than use new drugs, Dr Jindani’s main efforts are going into making one of the existing drugs – rifampicin – more effective by increasing its dose in the hope that treatment can come down to four months.

She is leading a new trial, RIFASHORT, to test using higher doses of rifampicin, and to have just four months of treatment.

She said: “In one arm we’re doubling the dose of rifampicin, in another we’re tripling the dose of rifampicin for four months”, she said, “because we have some pre-clinical evidence that that might kill off the persisting bacteria, and that’s the aim now, to eliminate the persistent bacteria”.

Another St George’s expert, Professor Julia Critchley is Professor of Epidemiology in the Population Health Research Institute, spoke to the delegates at the INTERTB meeting about her concerns regarding the concern that people with diabetes are three-times more likely to get TB than people without diabetes, possibly because their immune system is less effective in a way that the TB bacteria exploit.

Genetic factors and diet changes are considered the most probable causes of the rise in diabetes in Africa and Asia.

Dr Jindani said, “So Indians have a genetic disposition to developing diabetes. In the other countries, diets are changing. For example in the past I never saw a fat person in Africa, and now I do, because they’re all eating junk food. There again the levels of diabetes are going up exponentially, and they risk getting TB.”

Source:

https://sgul.ac.uk/news/news-archive/experts-tackling-deadly-tuberculosis-say-thousands-are-dying-of-the-curable-disease-each-day

Tagged with:

About author

Related Articles